It’s always a good sign when any stock finishes the day on its daily high. Keep with NEM , the rumblings and tea-leaf diehards see this going much higher. The dynamics are set for a rising cost base (AISC), significantly outweighed by a rising revenue base (POG). Task for management here is to keep a tight ship , don’t be complacent and keep searching for organic growth . That’s Palmer’s job.
- Forums
- ASX - By Stock
- NEM
- Ann: Second Quarter 2024 Results Release (Form 8-K)
Ann: Second Quarter 2024 Results Release (Form 8-K), page-8
Featured News
Add NEM (ASX) to my watchlist
(20min delay)
|
|||||
Last
$63.63 |
Change
0.500(0.79%) |
Mkt cap ! $7.839B |
Open | High | Low | Value | Volume |
$63.01 | $63.66 | $63.01 | $6.015M | 94.82K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1153 | $63.62 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$63.66 | 674 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 97 | 63.550 |
3 | 172 | 63.540 |
3 | 117 | 63.530 |
5 | 231 | 63.520 |
6 | 310 | 63.510 |
Price($) | Vol. | No. |
---|---|---|
63.570 | 41 | 4 |
63.580 | 98 | 2 |
63.590 | 1 | 1 |
63.600 | 377 | 2 |
63.610 | 80 | 1 |
Last trade - 11.45am 18/11/2024 (20 minute delay) ? |
Featured News
NEM (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online